STEPHEN DELCASINO: Open Payments
NPI 1972944494 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 56 payments from 17 companies in 2025. Trend: 2023 $1,413 · 2024 $1,666 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $233 |
| ACCORD HEALTHCARE, INC. | 8 | $163 |
| Telix Pharmaceuticals | 7 | $158 |
| UROGEN PHARMA, INC. | 5 | $131 |
| Antares Pharma, Inc. | 5 | $78 |
| Boston Scientific Corporation | 3 | $61 |
| Endo USA, Inc. | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $57 |
| Dendreon Pharmaceuticals LLC | 2 | $52 |
| ABBVIE INC. | 2 | $41 |
Products named: Xtandi, Camcevi, ILLUCCIX, JELMYTO, XYOSTED, XIAFLEX, ERLEADA, PROVENGE.
Industry payments across NV — which companies pay providers there.
